Assets that temporarily lose their peg will generally lose it in the downward direction, which would cause the redeemable value of an LP token to be less than its virtual price-derived Enzyme value. This condition is not susceptible to investor-side arbitrage in Enzyme funds, where the concern is preventing the purchase of discounted shares (whereas using the virtual price results in temporarily inflated share price). Further, as long as the loss of peg is assumed to be temporary, using the virtual price rather than this ephemeral imbalance protects the fund from discounted shares.